Terms: = Pancreatic cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
39 results:
1. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
[TBL] [Abstract] [Full Text] [Related]
2. Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-agent fibroblast growth factor receptor-specific inhibitors in pancreatic cancer.
Lin Q; Serratore A; Perri J; Roy Chaudhuri T; Qu J; Ma WW; Kandel ES; Straubinger RM
Br J Pharmacol; 2024 May; 181(9):1383-1403. PubMed ID: 37994108
[TBL] [Abstract] [Full Text] [Related]
3. Integrated Workflow for the Label-Free Isolation and Genomic Analysis of Single Circulating Tumor Cells in pancreatic cancer.
Rupp B; Owen S; Ball H; Smith KJ; Gunchick V; Keller ET; Sahai V; Nagrath S
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887203
[TBL] [Abstract] [Full Text] [Related]
4. fgfr3 Nuclear Translocation Contributes to Proliferative Potential and Poor Prognosis in pancreatic Ductal Adenocarcinoma.
Zhou L; Lu J; Liang ZY; Zhou WX; Jiang BL; Wang YZ; Liu CX; Huang BW; You L; Guo JC
Pancreas; 2022 May; 51(5):476-482. PubMed ID: 35858182
[TBL] [Abstract] [Full Text] [Related]
5. CD93 orchestrates the tumor microenvironment and predicts the molecular subtype and therapy response of bladder cancer.
Zheng X; Xu H; Lin T; Tan P; Xiong Q; Yi X; Qiu S; Yang L; Shen B; Ai J; Wei Q
Comput Biol Med; 2022 Aug; 147():105727. PubMed ID: 35785664
[TBL] [Abstract] [Full Text] [Related]
6. Molecular Characterization of KRAS Wild-type Tumors in Patients with pancreatic Adenocarcinoma.
Philip PA; Azar I; Xiu J; Hall MJ; Hendifar AE; Lou E; Hwang JJ; Gong J; Feldman R; Ellis M; Stafford P; Spetzler D; Khushman MM; Sohal D; Lockhart AC; Weinberg BA; El-Deiry WS; Marshall J; Shields AF; Korn WM
Clin Cancer Res; 2022 Jun; 28(12):2704-2714. PubMed ID: 35302596
[TBL] [Abstract] [Full Text] [Related]
7. Anticancer drug resistance: An update and perspective.
Nussinov R; Tsai CJ; Jang H
Drug Resist Updat; 2021 Dec; 59():100796. PubMed ID: 34953682
[TBL] [Abstract] [Full Text] [Related]
8. Novel insights into immunohistochemical analysis for diagnosing serous neoplasm of the pancreas: aquaporin 1, stereocilin, and transmembrane protein 255B.
Watase C; Fuse M; Ino Y; Naito C; Hiraoka N
Histopathology; 2021 Nov; 79(5):872-879. PubMed ID: 34288030
[TBL] [Abstract] [Full Text] [Related]
9. Complications After Complex Gastrointestinal cancer Surgery: Benefits and Costs Associated with Inter-hospital Transfer Among Medicare Beneficiaries.
Pathak P; Dalmacy D; Tsilimigras DI; Hyer JM; Diaz A; Pawlik TM
J Gastrointest Surg; 2021 Jun; 25(6):1370-1379. PubMed ID: 33914214
[TBL] [Abstract] [Full Text] [Related]
10. Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation.
Pfitzinger PL; Fangmann L; Wang K; Demir E; Gürlevik E; Fleischmann-Mundt B; Brooks J; D'Haese JG; Teller S; Hecker A; Jesinghaus M; Jäger C; Ren L; Istvanffy R; Kühnel F; Friess H; Ceyhan GO; Demir IE
J Exp Clin Cancer Res; 2020 Dec; 39(1):289. PubMed ID: 33357230
[TBL] [Abstract] [Full Text] [Related]
11. Whole-exome sequencing reveals potential mechanisms of drug resistance to fgfr3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine.
Tong Z; Yan C; Dong YA; Yao M; Zhang H; Liu L; Zheng Y; Zhao P; Wang Y; Fang W; Zhang F; Jiang W
BMC Med Genomics; 2020 Sep; 13(1):138. PubMed ID: 32957974
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, fgfr3 and TATI in Bladder cancers.
Matuszczak M; Salagierski M
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397531
[TBL] [Abstract] [Full Text] [Related]
13. NATURALLY-OCCURRING AUTOANTIBODIES TO HUMAN CHORIONIC GONADOTROPIN AND ITS SUBUNITS IN OVARIAN CYST PATIENTS.
Chikadze N; Tevzadze M; Janelidze M; Porakishvili N
Georgian Med News; 2020 Jan; (298):100-105. PubMed ID: 32141859
[TBL] [Abstract] [Full Text] [Related]
14. Precision medicine for human cancers with Notch signaling dysregulation (Review).
Katoh M; Katoh M
Int J Mol Med; 2020 Feb; 45(2):279-297. PubMed ID: 31894255
[TBL] [Abstract] [Full Text] [Related]
15. Exome-Wide Association Study of pancreatic cancer Risk.
Grant RC; Denroche RE; Borgida A; Virtanen C; Cook N; Smith AL; Connor AA; Wilson JM; Peterson G; Roberts NJ; Klein AP; Grimmond SM; Biankin A; Cleary S; Moore M; Lemire M; Zogopoulos G; Stein L; Gallinger S
Gastroenterology; 2018 Feb; 154(3):719-722.e3. PubMed ID: 29074453
[TBL] [Abstract] [Full Text] [Related]
16. Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors.
Siemers NO; Holloway JL; Chang H; Chasalow SD; Ross-MacDonald PB; Voliva CF; Szustakowski JD
PLoS One; 2017; 12(7):e0179726. PubMed ID: 28749946
[TBL] [Abstract] [Full Text] [Related]
17. Nuclear translocation of fibroblast growth factor receptor 3 and its significance in pancreatic cancer.
Zhou L; Yao LT; Liang ZY; Zhou WX; You L; Shao QQ; Huang S; Guo JC; Zhao YP
Int J Clin Exp Pathol; 2015; 8(11):14640-8. PubMed ID: 26823787
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets.
Lee H; Wang K; Johnson A; Jones DM; Ali SM; Elvin JA; Yelensky R; Lipson D; Miller VA; Stephens PJ; Javle M; Ross JS
J Clin Pathol; 2016 May; 69(5):403-8. PubMed ID: 26500333
[TBL] [Abstract] [Full Text] [Related]
19. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2.
Inaguma S; Ito H; Riku M; Ikeda H; Kasai K
Oncotarget; 2015 Sep; 6(29):28257-68. PubMed ID: 26318045
[TBL] [Abstract] [Full Text] [Related]
20. Association of cholesterol with risk of pancreatic cancer: a meta-analysis.
Wang J; Wang WJ; Zhai L; Zhang DF
World J Gastroenterol; 2015 Mar; 21(12):3711-9. PubMed ID: 25834340
[TBL] [Abstract] [Full Text] [Related]
[Next]
